NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company converging science and technology in the United States, the United Kingdom, Singapore, and Canada. More Details
Slightly overvalued with concerning outlook.
Share Price & News
How has NantHealth's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NH's share price has been volatile over the past 3 months.
7 Day Return
US Healthcare Services
1 Year Return
US Healthcare Services
Return vs Industry: NH exceeded the US Healthcare Services industry which returned 72% over the past year.
Return vs Market: NH exceeded the US Market which returned 15.6% over the past year.
Price Volatility Vs. Market
How volatile is NantHealth's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 days ago | Simply Wall StDid Business Growth Power NantHealth's (NASDAQ:NH) Share Price Gain of 243%?
3 months ago | Simply Wall StWhy NantHealth, Inc. (NASDAQ:NH) Could Be Worth Watching
5 months ago | Simply Wall StBefore You Buy NantHealth, Inc. (NASDAQ:NH), Consider Its Volatility
Is NantHealth undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NH ($2.34) is trading below our estimate of fair value ($9.71)
Significantly Below Fair Value: NH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: NH is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.
PE vs Market: NH is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NH has negative assets, so we can't compare its PB Ratio to the US Healthcare Services industry average.
How is NantHealth forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NH's revenue (10.1% per year) is forecast to grow faster than the US market (10% per year).
High Growth Revenue: NH's revenue (10.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NH is forecast to be unprofitable in 3 years.
How has NantHealth performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NH is currently unprofitable.
Growing Profit Margin: NH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NH is unprofitable, and losses have increased over the past 5 years at a rate of 1.3% per year.
Accelerating Growth: Unable to compare NH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).
Return on Equity
High ROE: NH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is NantHealth's financial position?
Financial Position Analysis
Short Term Liabilities: NH has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NH has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NH has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: NH's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if NH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is NantHealth current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NH's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Patrick Soon-Shiong (67 yo)
Dr. Patrick Soon-Shiong, M.D., FRCS (C), FACS, MBBCh, MSc, FRCS (C), is an Owner of Los Angeles Times Communications, LLC. Dr. Soon-Shiong is a physician, surgeon and scientist, invented and developed the ...
|Founder||10.25yrs||no data||no data|
|Chief Financial Officer||2.08yrs||US$685.07k||0.12% |
|Chief Operating Officer||3.42yrs||US$928.33k||0.28% |
|Senior VP & General Counsel||3yrs||no data||no data|
|Senior VP of Global Sales & Marketing||2.75yrs||no data||no data|
|Senior Vice President of Human Resources||2.67yrs||no data||no data|
|Chief Medical Officer||3.42yrs||no data||no data|
|Senior Vice President of Client Services||3yrs||no data||no data|
|Senior Vice President of Product Management & Development||3yrs||no data||no data|
Experienced Management: NH's management team is considered experienced (3 years average tenure).
|Founder||10.25yrs||no data||no data|
|Independent Director||4.42yrs||US$184.12k||0.13% |
|Independent Director||4.42yrs||US$177.24k||0.13% |
|Independent Director||4.42yrs||US$176.88k||0.13% |
|Independent Director||0.58yr||no data||no data|
Experienced Board: NH's board of directors are considered experienced (4.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
NantHealth, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: NantHealth, Inc.
- Ticker: NH
- Exchange: NasdaqGS
- Founded: 2010
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$259.796m
- Shares outstanding: 111.02m
- Website: https://nanthealth.com
Number of Employees
- NantHealth, Inc.
- 9920 Jefferson Boulevard
- Culver City
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NH||NasdaqGS (Nasdaq Global Select)||Yes||Common Shares||US||USD||Jun 2016|
|NEL||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Jun 2016|
NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company converging science and technology in the United States, the United Kingdom, Singapore, and Canada. It provides ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/27 23:53|
|End of Day Share Price||2020/10/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.